← Back to Vaccine Database

Attenuvax

Live attenuated vaccine · VDDBV0102

Target & Classification

HIVHuman immunodeficiency virus
Live attenuated vaccine
HIV Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT00000815 Phase 2HIV Infections